This unique volume in our Drugs and Pharmaceutical Sciences series covers the development of gene therapy today, the technology involved, clinical applications of siRNA, non-viral vector-based mRNA delivery using nanotechnology, and RNA based vaccines for treating the infectious diseases. It also presents the current application of the CRISPR/Cas9 gene-editing technique which has revolutionized genome editing and which was awarded the 2020 Nobel Prize in Chemistry. Several new drug delivery systems are explored for the applications of gene therapy. These are found to be useful in treating chronic illnesses, including cancer and infectious diseases.
Key Features:
- Overview of the development of gene therapy
- Provides the most up to date information on the development of gene therapy, from the technology involved to gene correction and genome editing
- Presents CRISPR gene therapy recent trends and applications
- Discusses siRNA, mRNA, and DNA plasmids
Author(s): Yashwant Pathak
Series: Drugs and the Pharmaceutical Sciences
Publisher: CRC Press
Year: 2022
Language: English
Pages: 316
City: Boca Raton
Cover
Half Title
Series
Title
Copyright
Dedication
Contents
Preface
About the Editor
List of Contributors
Chapter 1 Overview of Development of Gene Therapy
Chapter 2 Understanding the Technologies Involved in Gene Therapy
Chapter 3 Gene Therapy and Gene Correction: Target, Progress and Challenges to Treat Human Diseases
Chapter 4 Clinical Applications of siRNA
Chapter 5 Human Genomics Projects, Gene Therapy and Precision Medicine
Chapter 6 The Current State of NonViral Vector–Based mRNA Medicine Using Various Nanotechnology Applications
Chapter 7 RNABased Vaccines for Infectious Disease
Chapter 8 Conditional Replication of Oncolytic Virus Based on Detection of Oncogenic mRNA
Chapter 9 Unilateral Ex Vivo Gene Therapy by GDNF in Neurodegenerative Diseases
Chapter 10 Gene Therapy for Cancer Treatment: Recent Trends and Clinical Evidence
Chapter 11 Gene Therapy for Retina and Eye Diseases
Chapter 12 COVID19 Vaccine Development and Applications
Chapter 13 In Vivo Gene Therapy: AAV2 Vectors
Chapter 14 Gene Therapy for Acquired Tissue Damage: Scope, Quality, NonClinical and Clinical Guidelines of Gene Therapy Medical Products
Chapter 15 iMRI for Clinical Gene Therapy
Index